Altered lung biology of healthy never smokers following acute inhalation of E-cigarettes

Respiratory Research

Volumn 19, Issue 1, 2018, Pages

  Staudt, Michelle R ^a   Salit, Jacqueline ^a   Kaner, Robert J ^a   Hollmann, Charleen ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; CIGARETTE SMOKE; FORKHEAD BOX PROTEIN M1; MESSENGER RNA; NDC80 COMPLEX; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA1; NICOTINIC RECEPTOR ALPHA10; NICOTINIC RECEPTOR ALPHA3; NICOTINIC RECEPTOR ALPHA5; NICOTINIC RECEPTOR BETA1; PROSTAGLANDIN E RECEPTOR 3; UNCLASSIFIED DRUG;

ADULT; AIRWAY EPITHELIUM CELL; AMOTL2 GENE; ARTICLE; ATAD2 GENE; BLOOD LEVEL; CAPILLARY ENDOTHELIUM; COHORT ANALYSIS; CONTROLLED STUDY; CORO1A GENE; DOWN REGULATION; EDN1 GENE; ENDOTHELIAL MICROPARTICLE; EXPOSURE; FEMALE; FIBEROPTIC BRONCHOSCOPY; FLOW CYTOMETRY; FOXM1 GENE; GDA GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GNB1L GENE; HUMAN; HUMAN CELL; KCNK15 GENE; LATS2 GENE; LUNG ALVEOLUS MACROPHAGE; LUNG CAPILLARY; LUNG FUNCTION; MALE; MKI67 GENE; NDC80 GENE; NORMAL HUMAN; PPP1R16B GENE; PROTEIN EXPRESSION; PTGER3 GENE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RNA SEQUENCE; RND3 GENE; RRM2 GENE; THORAX RADIOGRAPHY; UPREGULATION; VAPING; DRUG EFFECT; ELECTRONIC CIGARETTE; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG FUNCTION TEST; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; RESPIRATORY MUCOSA; SMOKING; TRENDS;

ADMINISTRATION, INHALATION; ADULT; COHORT STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUCOSA; SMOKING;

EID: 85046704333     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-018-0778-z     Document Type: Article

References (45)

1. Caponnetto P, Campagna D, Papale G, Russo C, Polosa R. The emerging phenomenon of electronic cigarettes. ExpertRevRespirMed. 2012;6:63-74.
2. McNeill AB, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie P.: E-cigarettes: an evidence update: a report commissioned by Public Health England. (England PH ed. London: PHE; 2015.
3. Physicians RCo. Nicotine without smoke: tobacco harm reduction. London: RCP; 2016. p. 2016.
4. Green SH, Bayer R, Fairchild AL. Evidence, policy, and E-cigarettes--will England reframe the debate? N Engl J Med. 2016;374:1301-3.
5. Hutzler C, Paschke M, Kruschinski S, Henkler F, Hahn J, Luch A. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol. 2014;88:1295-308.
6. Choi K, Fabian L, Mottey N, Corbett A, Forster J. Young adults' favorable perceptions of snus, dissolvable tobacco products, and electronic cigarettes: findings from a focus group study. AmJPublic Health. 2012;102:2088-93.
7. ASH: ASH fact sheet: Use of electronic cigarettes (vapourisers) among adults in Great Britan. In ASH Fact Sheet. http://www.ash.org.uk/files/documents/ASH_891.pdf ; 2016.
8. Ayers JW, Ribisl KM, Brownstein JS. Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance. AmJPrevMed. 2011;40:448-53.
9. McMillen R, Maduka J, Winickoff J. Use of emerging tobacco products in the United States. JEnvironPublic Health. 2012;2012:989474.
10. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. E-cigarette awareness, use, and harm perceptions in US adults. AmJPublic Health. 2012;102:1758-66.
11. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, Peto R, Zatonski W, Hsia J, Morton J, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet. 2012;380:668-79.
12. Cervellati F, Muresan XM, Sticozzi C, Gambari R, Montagner G, Forman HJ, Torricelli C, Maioli E, Valacchi G. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. ToxicolIn Vitro. 2014;28:999-1005.
13. Lerner CA, Sundar IK, Yao H, Gerloff J, Ossip DJ, McIntosh S, Robinson R, Rahman I. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoSOne. 2015;10:e0116732.
14. Schweitzer KS, Chen SX, Law S, Van DM, Poirier C, Justice MJ, Hubbard WC, Kim ES, Lai X, Wang M, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol. 2015;309:L175-87.
15. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini K, Consolini N, Cormier SA, Lomnicki S, Hasan F, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One. 2015;10:e0116861.
16. Schaal C, Chellappan SP. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res. 2014;12:14-23.
17. Auerbach O, Forman JB, Gere JB, Kassouny DY, Muehsam GE, Petrick TG, Smolin HJ, Stout AP. Changes in the bronchial epithelium in relation to smoking and cancer of the lung; a report of progress. N Engl J Med. 1957;256:97-104.
18. Harvey BG, Heguy A, Leopold PL, Carolan BJ, Ferris B, Crystal RG. Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med (Berl). 2007;85:39-53.
19. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-53.
20. Russi TJC, R. G.: Use of bronchoalveolar lavage and airway brushing to investigate the human lung. In The lung: Scientific Foundations. Second Edition edition. Edited by Crystal RGW, J.B.; Weibel,E.R.; Barnes, P.J. Philadelphia: Lippincott-Raven Publishers; 1997: 371-382.
21. Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, O'Connor TP, Crystal RG. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol. 2009;183:2867-83.
22. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, Strulovici-Barel Y, Mezey JG, Crystal RG. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med. 2011;184:224-32.
23. Strulovici-Barel Y, Staudt MR, Krause A, Gordon C, Tilley AE, Harvey BG, Kaner RJ, Hollmann C, Mezey JG, Bitter H, et al. Persistence of circulating endothelial microparticles in COPD despite smoking cessation. Thorax. 2016;
24. Hackett NR, Butler MW, Shaykhiev R, Salit J, Omberg L, Rodriguez-Flores JL, Mezey JG, Strulovici-Barel Y, Wang G, Didon L, Crystal RG. RNA-Seq quantification of the human small airway epithelium transcriptome. BMC Genomics. 2012;13:82.
25. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009;89:73-120.
26. Lee HW, Park SH, Weng MW, Wang HT, Huang WC, Lepor H, Wu XR, Chen LC, Tang MS. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci U S A. 2018;115:E1560-9.
27. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015;372:392-4.
28. Varlet V, Farsalinos K, Augsburger M, Thomas A, Etter JF. Toxicity assessment of refill liquids for electronic cigarettes. Int J Environ Res Public Health. 2015;12:4796-815.
29. Uchiyama S, Ohta K, Inaba Y, Kunugita N. Determination of carbonyl compounds generated from the E-cigarette using coupled silica cartridges impregnated with hydroquinone and 2,4-dinitrophenylhydrazine, followed by high-performance liquid chromatography. Anal Sci. 2013;29:1219-22.
30. Lim HB, Kim SH. Inhallation of e-cigarette cartridge solution aggravates allergen-induced airway inflammation and hyper-responsiveness in mice. ToxicolRes. 2014;30:13-8.
31. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23(Suppl 2):ii36-40.
32. Reidel B, Radicioni G, Clapp PW, Ford AA, Abdelwahab S, Rebuli ME, Haridass P, Alexis NE, Jaspers I, Kesimer M. E-cigarette use causes a unique innate immune response in the lung, involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med. 2018;197:492-501.
33. Lozano G. The enigma of p53. Cold Spring Harb Symp Quant Biol. 2016;81:37-40.
34. Meek DW. Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer. 2009;9:714-23.
35. Yee KS, Vousden KH. Complicating the complexity of p53. Carcinogenesis. 2005;26:1317-22.
36. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, Ritchey DM, Miller YE. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest. 1997;100:2133-7.
37. Shaykhiev R, Wang R, Zwick RK, Hackett NR, Leung R, Moore MA, Sima CS, Chao IW, Downey RJ, Strulovici-Barel Y, et al. Airway basal cells of healthy smokers express an embryonic stem cell signature relevant to lung cancer. Stem Cells. 2013;31:1992-2002.
38. Toyooka S, Tsuda T, Gazdar AF. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat. 2003;21:229-39.
39. Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD, Gazdar AF. Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst. 1997;89:1366-73.
40. Gartel AL. FOXM1 in Cancer: interactions and vulnerabilities. Cancer Res. 2017;77:3135-9.
41. Balli D, Ren X, Chou FS, Cross E, Zhang Y, Kalinichenko VV, Kalin TV. Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation. Oncogene. 2012;31:3875-88.
42. Lebender LF, Prünte L, Rumzhum NN, Ammit AJ. Selectively targeting prostanoid E (EP) receptor-mediated cell signalling pathways: implications for lung health and disease. Pulm Pharmacol Ther. 2018;49:75-87.
43. Aronoff DM, Canetti C, Peters-Golden M. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol. 2004;173:559-65.
44. Ballinger MN, Aronoff DM, McMillan TR, Cooke KR, Olkiewicz K, Toews GB, Peters-Golden M, Moore BB. Critical role of prostaglandin E2 overproduction in impaired pulmonary host response following bone marrow transplantation. J Immunol. 2006;177:5499-508.
45. Sadikot RT, Zeng H, Azim AC, Joo M, Dey SK, Breyer RM, Peebles RS, Blackwell TS, Christman JW. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2. Eur J Immunol. 2007;37:1001-9.